Tesaro Shares Multitude of Ovarian Cancer Treatment Findings at Madrid Conference
News
Half of ovarian cancer patients in a small study responded to a combination of Tesaro’s Zejula and Genentech’s Avastin, according to a presentation Tesaro made at the European Society of Medical Oncology (ESMO) 2017 ... Read more